The COVID-19 Pandemic and Enzyme Replacement Therapy in Lysosomal Storage Disorders
Aim:The coronavirus disease-2019 (COVID-19) pandemic has caused a worldwide public health emergency, especially affecting people with chronic illnesses including lysosomal storage disorders (LSDs). The unfavorable conditions due to COVID-19 have mostly affected people with chronic conditions, in ter...
Guardado en:
Autores principales: | Asburçe Olgaç, Çiğdem Seher Kasapkara, Burak Açıkel, Yılmaz Yıldız, Gülhan Karakaya Molla, Mustafa Kılıç |
---|---|
Formato: | article |
Lenguaje: | EN TR |
Publicado: |
Galenos Yayinevi
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e4ca6b06965e4c459c041dcca9d8acbe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease
por: Alícia Dorneles Dornelles, et al.
Publicado: (2021) -
The Association Between Lysosomal Storage Disorder Genes and Parkinson’s Disease: A Large Cohort Study in Chinese Mainland Population
por: Yu-wen Zhao, et al.
Publicado: (2021) -
Reproduction in Animal Models of Lysosomal Storage Diseases: A Scoping Review
por: Daniela Vuolo, et al.
Publicado: (2021) -
A Comprehensive, Targeted NGS Approach to Assessing Molecular Diagnosis of Lysosomal Storage Diseases
por: Valentina La Cognata, et al.
Publicado: (2021) -
El estudio HERS conmociona a la terapia de sustitución hormonal
por: Cano S,Antonio, et al.
Publicado: (2000)